These results illuminate the molecular mechanisms by which GDM negatively impacts offspring cardiac health and highlight the potential for targeting FTO-mediated RNA methylation pathways as a therapeutic strategy for GDM-related cardiac issues. The gene discussed is FTO; the disease is gestational diabetes.